Alentis Therapeutics AG
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreThese trailblazers have scaled beyond expectations—becoming industry leaders, job creators, and global ambassadors of Swiss excellence. Their journeys reflect the power of vision, resilience, and innovation. Discover the startups that are transforming industries and inspiring the world shapers of tomorrow.
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreenabler of the digitized supply chain
Read moreDeveloping cures for serious human genetic diseases
Read moreTherapeutic bacteria for treating cancer & genetic disorders
Read moreInstruments for dynamic signal analysis
Read moreBringing real emotion to virtual reality
Read moreMaking Sense of Robotic Surgery
Read moreImmunotherapies for cancer
Read more